BRIEF published on 03/20/2025 at 21:50, 19 days 22 hours ago Poxel Releases Positive Preclinical Results for HCM Treatment Preclinical Study Hypertrophic Cardiomyopathy PXL065 Myocardial Remodeling Cardiac Fibrosis
PRESS RELEASE published on 03/20/2025 at 21:45, 19 days 22 hours ago Inside Information / Other news releases Poxel announces positive preclinical study results for PXL065, a potential treatment for Hypertrophic Cardiomyopathy, showing benefits in a mouse model Preclinical Study Poxel Hypertrophic Cardiomyopathy PXL065 Mouse Model
BRIEF published on 02/11/2025 at 20:33, 1 month 25 days ago Poxel Holds Combined General Meeting, Announces Key Results General Meeting Shareholder Voting Financial Delegations Remuneration Policy Poxel SA
PRESS RELEASE published on 02/11/2025 at 20:28, 1 month 26 days ago Inside Information / Other news releases Poxel announces results of its Combined General Meeting with approved resolutions on revised remuneration policy for corporate officers. Details available on company's website Voting Results Financial Press Release Combined General Meeting Poxel Remuneration Policy
BRIEF published on 01/31/2025 at 07:35, 2 months 9 days ago POXEL Announces Growing Sales of TWYMEEG in Japan for 2024 Poxel Sumitomo Pharma TWYMEEG Japan Sales 2024 Revenues
BRIEF published on 01/20/2025 at 07:35, 2 months 20 days ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 2 months 20 days ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 3 months 17 days ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
PRESS RELEASE published on 12/23/2024 at 07:30, 3 months 17 days ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Poxel SA announces availability of its 2024 half-year financial report, including condensed financial statements and activities for June 30, 2024 Biopharmaceutical Company Metabolic Disorders MASH 2024 Half-Year Financial Report Poxel SA
BRIEF published on 12/09/2024 at 07:35, 4 months ago Poxel Announces Financial Challenges and Outlines Future Strategy Financial Results General Meeting Bonds Redemption Cash Runway Poxel SA
Published on 04/09/2025 at 20:10, 22 minutes ago Taranis Quantifies Hydrothermal Alteration System at Thor to Improve Targeting for 2025 Deep Exploration Drilling
Published on 04/09/2025 at 18:00, 2 hours 32 minutes ago BrooQLy Inc. (BRQL) dba Dynamic Aerospace Systems Appoints FedEx Leader in Logistics to Board of Directors
Published on 04/09/2025 at 15:15, 5 hours 17 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 04/09/2025 at 15:00, 5 hours 32 minutes ago The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt During the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 15:00, 5 hours 32 minutes ago The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt during the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 20:20, 12 minutes ago Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 14 minutes ago EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 1 hour 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:34, 1 hour 58 minutes ago PolyPeptide announces results of the annual General Meeting 2025
Published on 04/09/2025 at 18:02, 2 hours 29 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/09/2025 at 18:59, 1 hour 32 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 hour 34 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 2 hours 47 minutes ago COGELEC : 2024 full-year results and Q1 2025 revenue.
Published on 04/09/2025 at 17:40, 2 hours 52 minutes ago COGELEC : Statement on the total number of shares and voting rights.
Published on 04/09/2025 at 08:00, 12 hours 32 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
